Symbols / KROS Stock $11.44 +1.15% Keros Therapeutics, Inc.

Healthcare • Biotechnology • United States • NGM
KROS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Market Cap 348.53M Enterprise Value -47.53M Income 87.01M Sales 244.06M Book/sh 15.51 Cash/sh 14.58
Dividend Yield — Payout 0.00% Employees 78 IPO — P/E 4.97 Forward P/E -2.26
PEG — P/S 1.43 P/B 0.74 P/C — EV/EBITDA -0.66 EV/Sales -0.20
Quick Ratio 15.10 Current Ratio 15.45 Debt/Eq 5.57 LT Debt/Eq — EPS (ttm) 2.30 EPS next Y -5.05
EPS Growth — Revenue Growth -87.30% Earnings 2026-05-11 ROA 9.25% ROE 19.90% ROIC —
Gross Margin 47.90% Oper. Margin -75.77% Profit Margin 35.65% Shs Outstand 19.72M Shs Float 19.12M Short Float 29.74%
Short Ratio 2.62 Short Interest — 52W High 22.55 52W Low 10.41 Beta 0.99 Avg Volume 410.56K
Volume 180.93K Target Price $22.57 Recom None Prev Close $11.31 Price $11.44 Change 1.15%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$60.47
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest KROS news

No recent news from Yahoo. Try the RSS feed for latest KROS news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-15 BIENAIME JEAN-JACQUES Director — 1,000 $11.70 $11,700
2026-04-02 SEEHRA JASBIR Chief Executive Officer — 55,000 $0.30 $16,500
2026-03-09 BIENAIME JEAN-JACQUES Director — 2,000 $11.21 $22,420
2026-03-09 NEWTON CHARLES W. Director — 13,215 $0.00 $0
2026-02-19 SEEHRA JASBIR Chief Executive Officer — 7,015 $16.17 $113,433
2026-02-18 REGNANTE KEITH C Chief Financial Officer — 4,739 $16.35 $77,483
2026-02-18 LERNER LORENA RAQUEL PH.D. Officer — 3,873 $16.35 $63,324
2026-02-18 CHO ESTHER General Counsel — 4,745 $16.35 $77,581
2025-10-15 PONTIFAX MANAGEMENT 4 G.P. 2015, LTD. Beneficial Owner of more than 10% of a Class of Security — 4,787,331 $14.49 $69,368,426
2025-10-15 ADAR1 CAPITAL MANAGEMENT LLC Beneficial Owner of more than 10% of a Class of Security — 5,389,264 $17.75 $95,659,436
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category